TyraTech, Inc. Lloyds and Day Lewis Pharmacy listings (7733F)

TIDMTYR TIDMTYRU

RNS Number : 7733F

TyraTech, Inc.

25 February 2015

25 February 2015

TyraTech, Inc.

("TyraTech" or the "Company")

Lloyds and Day Lewis Pharmacy listings

Vamousse(R) Advertising and Marketing Award

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is delighted to announce new listings for its Vamousse(R) Head Lice Treatment and Protective products with Lloyds Pharmacy and its Treatment product with Day Lewis Pharmacy in the UK.

Day Lewis, which began stocking the Vamousse range in January 2015, is the largest independent pharmacy chain in the UK with more than 200 outlets. Lloyds, a well respected household name at the forefront of community pharmacy, has a distribution network of more than 1600 outlets in the UK and is expected to commence stocking Vamousse products from March 2015.

Vamousse - broadening the distribution network

With distribution already established in Boots, Superdrug, Sainsbury's, Tesco and Rowlands, the addition of Lloyds and Day Lewis gives Vamousse a comprehensive UK distribution platform for 2015. Increasing the physical distribution points is particularly important for head lice products that tend to be emergency purchases. Customers need to be able to find the products close to home in order to solve their head lice problems as fast as possible.

Vamousse - advertising and marketing campaign award

TyraTech is particularly pleased that the Vamousse brand has won the Independent Community Pharmacy (ICP) magazine 'Pharmacy Product Of The Year - Best Advertising Campaign' award. This prestigious award is voted for by practicing pharmacists. The award recognises and reflects the strong awareness and engagement generated by the Vamousse marketing campaign amongst pharmacists and pharmacy staff. Their awareness and recommendation of the Vamousse Treatment and Protective range are key ingredients in the commercial success of these products.

Bruno Jactel CEO of TyraTech commented:

"We are delighted to announce these new listings for our Vamousse treatment and preventative products, taking us initially into more than 1300 new distribution points in the UK from March 2015.

"I am very pleased with our achievements in the UK marketplace in the eight months since the launch of the Vamousse product range. We are confident of continued positive developments as our comprehensive UK distribution platform reaps the benefits of our highly engaging and effective marketing campaign."

 
 
  For further information please contact:TyraTech, Inc. 
  Bruno Jactel, Chief Executive Officer                               Tel: [phone] 
  Vincent Morgus, Chief Financial Officer and                         Tel: [phone] 
  Treasurer 
  SPARK Advisory Partners Limited, Nominated 
  Adviser                                                            Tel: [phone] 
  Matt Davis / Mark Brady 
  Allenby Capital Limited, Joint Broker 
   Chris Crawford                                                    Tel: [phone] 
  Whitman Howard Limited, Joint Broker 
   Ranald McGregor-Smith / Niall Devins                                   Tel: [phone] 
                                                                                      4555 
  Walbrook, Financial PR and IR 
   Nick Rome/ Guy McDougall                                          Tel: [phone] 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCPKQDQOBKDNBB